Drug intelligence / Profile preview

imidacloprid + pyriproxyfen

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Topical
01

Overview

Imidacloprid + pyriproxyfen is a combination topical antiparasitic drug used in veterinary medicine, primarily for dogs and cats, to treat and prevent flea infestations and, in some cases, lice. **Imidacloprid** is a neonicotinoid insecticide that acts as a nicotinic acetylcholine receptor agonist, causing paralysis and death in adult fleas and lice. **Pyriproxyfen** is an insect growth regulator (IGR) that mimics juvenile insect hormones, inhibiting the development and maturation of flea eggs and larvae, thereby breaking the flea life cycle. The product is usually formulated as a spot-on solution applied to the animal’s skin monthly. It is distinct from other combinations that include permethrin, which are only for dogs[2][9][11][13].

Brand names
Advantage IIAdvantage PlusProvecta II
02

Targets

Nicotinic Acetylcholine ReceptorMET (Mesenchymal-epithelial transition factor receptor)

Beyond the preview

Go deeper on imidacloprid + pyriproxyfen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on imidacloprid + pyriproxyfen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call